Differential Predictors and Clinical Implications Associated With Long-Term Survivors in IDH Wildtype and Mutant Glioblastoma

BACKGROUND: Glioblastoma (GBM) is the most aggressive intracranial tumor which can be divided into two subtypes based on status of isocitrate dehydrogenase (IDH). A small fraction of patients after receiving standard treatment can be long-term survivors (LTS). This study was designed to disclose the...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Haihui, Yu, Kefu, Cui, Yong, Ren, Xiaohui, Li, Mingxiao, Zhang, Guobin, Yang, Chuanwei, Zhao, Xuzhe, Zhu, Qinghui, Lin, Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155513/
https://www.ncbi.nlm.nih.gov/pubmed/34055603
http://dx.doi.org/10.3389/fonc.2021.632663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155513/
https://www.ncbi.nlm.nih.gov/pubmed/34055603
http://dx.doi.org/10.3389/fonc.2021.632663

Ejemplares similares